S. Skerratt

The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain

S. Skerratt, Mark D. Andrews, Sharan K. Bagal et al. · Journal of Medicinal Chemistry · 2016 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Evaluation and Characterization of Trk Kinase Inhibitors for the Treatment of Pain: Reliable Binding Affinity Predictions from Theory and Computation

Shunzhou Wan, Agastya P. Bhati, S. Skerratt et al. · Journal of Chemical Information and Modeling · 2017 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain

Sharan K. Bagal, Mark D. Andrews, Bruce M. Bechle et al. · Journal of Medicinal Chemistry · 2018 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Characterization of the<scp>EP</scp>receptor subtype that mediates the inhibitory effects of prostaglandin E₂on IgE‐dependent secretion from human lung mast cells

Linda J. Kay, Mary E. Gilbert, Nick Pullen et al. · Clinical & Experimental Allergy · 2013 · 29 citations

Life Sciences, Immunology, Pharmacology +17

Synthesis of α,α-disubstituted unnatural amino acid derivatives using the aza-[2,3]-Wittig sigmatropic rearrangement

James C. Anderson, S. Skerratt · Journal of the Chemical Society Perkin Transactions 1 · 2002 · 27 citations

Natural Sciences, Chemistry, Medicinal Chemistry +14